Effect of Lymphadenectomy on Survival in Early-Stage Type II Endometrial Carcinoma and Carcinosarcoma

Table 4

Overall and recurrence-free survival of patients with type II endometrial carcinoma.

	No nodal dissection (n = 69)	Systematic nodal dissection (n = 66)
Overall survival
Died	31 (45%)	17 (26%)
3 years	66.5%	78.5%
5 years	44.3%	54.0%
Recurrence-free survival
Relapsed or died	32 (46%)	17 (26%)
3 years	59.5%	78.0%
5 years	51.1%	60.0%

Data are number of patients (%) or percentage survival.